India Glycols Limited (INDIAGLYCO) - Total Assets
Based on the latest financial reports, India Glycols Limited (INDIAGLYCO) holds total assets worth Rs65.23 Billion INR (≈ $705.43 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore INDIAGLYCO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
India Glycols Limited - Total Assets Trend (2005–2026)
This chart illustrates how India Glycols Limited's total assets have evolved over time, based on quarterly financial data. See INDIAGLYCO net asset value for net asset value and shareholders' equity analysis.
India Glycols Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
India Glycols Limited's total assets of Rs65.23 Billion consist of 23.0% current assets and 77.0% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.8% |
| Accounts Receivable | Rs3.51 Billion | 5.4% |
| Inventory | Rs8.91 Billion | 13.7% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs14.60 Million | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2005–2026)
This chart illustrates how India Glycols Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see INDIAGLYCO market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: India Glycols Limited's current assets represent 23.0% of total assets in 2026, a decrease from 38.4% in 2005.
- Cash Position: Cash and equivalents constituted 0.8% of total assets in 2026, up from 0.7% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is inventory at 13.7% of total assets.
India Glycols Limited Competitors by Total Assets
Key competitors of India Glycols Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
TAURUS ENERGY AB B SK120
F:8LU
|
Germany | €12.96 Million |
|
Zangge Holding Co Ltd
SHE:000408
|
China | CN¥18.95 Billion |
|
Sichuan Hebang Biotechnology Co Ltd
SHG:603077
|
China | CN¥29.29 Billion |
|
Zhejiang Yonghe Refrigerant Co Ltd
SHG:605020
|
China | CN¥8.67 Billion |
|
Epoxy Base Electronic Material Corp Ltd
SHG:603002
|
China | CN¥6.04 Billion |
|
Suzhou Hesheng Special Material Co Ltd
SHE:002290
|
China | CN¥2.14 Billion |
|
Shanghai Chlor-Alkali Chemical Co Ltd A
SHG:600618
|
China | CN¥14.24 Billion |
|
Hubei Jianghan New Materials Co. Ltd. A
SHG:603281
|
China | CN¥5.30 Billion |
India Glycols Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.74 | 0.78 | 0.97 |
| Quick Ratio | 0.30 | 0.28 | 0.62 |
| Cash Ratio | 0.00 | 0.03 | 0.00 |
| Working Capital | Rs-5.16 Billion | Rs-5.05 Billion | Rs-574.98 Million |
India Glycols Limited - Advanced Valuation Insights
This section examines the relationship between India Glycols Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.20 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 5.6% |
| Total Assets | Rs65.23 Billion |
| Market Capitalization | $831.75 Million USD |
Valuation Analysis
Below Book Valuation: The market values India Glycols Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: India Glycols Limited's assets grew by 5.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for India Glycols Limited (2005–2026)
The table below shows the annual total assets of India Glycols Limited from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs65.23 Billion ≈ $705.43 Million |
+5.62% |
| 2025-03-31 | Rs61.76 Billion ≈ $667.92 Million |
+9.96% |
| 2024-03-31 | Rs56.17 Billion ≈ $607.44 Million |
+15.61% |
| 2023-03-31 | Rs48.58 Billion ≈ $525.41 Million |
+4.92% |
| 2022-03-31 | Rs46.31 Billion ≈ $500.79 Million |
+12.42% |
| 2021-03-31 | Rs41.19 Billion ≈ $445.48 Million |
+0.81% |
| 2020-03-31 | Rs40.86 Billion ≈ $441.91 Million |
+7.98% |
| 2019-03-31 | Rs37.84 Billion ≈ $409.26 Million |
+10.60% |
| 2018-03-31 | Rs34.21 Billion ≈ $370.02 Million |
-2.03% |
| 2017-03-31 | Rs34.92 Billion ≈ $377.67 Million |
+16.54% |
| 2016-03-31 | Rs29.97 Billion ≈ $324.06 Million |
-5.00% |
| 2015-03-31 | Rs31.54 Billion ≈ $341.14 Million |
-2.73% |
| 2014-03-31 | Rs32.43 Billion ≈ $350.70 Million |
+4.01% |
| 2013-03-31 | Rs31.18 Billion ≈ $337.18 Million |
+0.11% |
| 2012-03-31 | Rs31.14 Billion ≈ $336.82 Million |
+28.92% |
| 2011-03-31 | Rs24.16 Billion ≈ $261.26 Million |
+16.64% |
| 2010-03-31 | Rs20.71 Billion ≈ $223.98 Million |
+15.95% |
| 2009-03-31 | Rs17.86 Billion ≈ $193.18 Million |
+22.49% |
| 2008-03-31 | Rs14.58 Billion ≈ $157.71 Million |
+21.63% |
| 2007-03-31 | Rs11.99 Billion ≈ $129.67 Million |
+21.97% |
| 2006-03-31 | Rs9.83 Billion ≈ $106.31 Million |
+28.38% |
| 2005-03-31 | Rs7.66 Billion ≈ $82.81 Million |
-- |
About India Glycols Limited
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and nat… Read more